Pharmalucence declared that it has chosen Integrated Project Services (IPS) to offer architectural design, technology and construction services for its proposed high-tech pharmaceutical manufacturing facility to be located in Billerica, MA.
The privately held company resists the current trend of shifting the manufacturing facilities outside the USA by the proposal of building its aseptic production facility in Billerica, MA. The new facility will offer permanent employment opportunities to 25 to 30 people during the next two years.
Pharmalucence has already commenced the first phase of its building agenda to facilitate moving part of its operations to the new construction in the last part of 2011. The company is planning to complete all the construction phases of the building by the middle of 2012 to commence its full-fledged drug production in the middle of 2013. The construction project has received a partial grant for the construction under the Massachusetts Recovery Zone Facility Bond program provided on behalf of the company by Mass-Development.
According to Ed Connolly, Chief Operating Officer of Pharmalucence, the company is making the investment in the life sciences industry of Boston area to establish a modern manufacturing facility to produce its own products and the products of other clients. He added that the new construction will feature sophisticated aseptic technologies in association with IPS.
Source: http://www.pharmalucence.com